curcumin III

structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Abbaoui, Abdellatif: 1 article (06/2019)
2.	Bouyatas, Moulay Mustapha: 1 article (06/2019)
3.	El Khiat, Abdelaati: 1 article (06/2019)
4.	Gamrani, Halima: 1 article (06/2019)
5.	Tamegart, Lahcen: 1 article (06/2019)

1.	Neurodegenerative Diseases (Neurodegenerative Disease) 06/01/2019 - "Our data results proved, on the one hand, an evident neurotoxic effect of acute Pb exposure and, on the other hand, a potent therapeutic effect of curcumin-III. Thereby, this compound may be recommended as a neuroprotective molecule for neurodegenerative disorders involving catecholaminergic impairment initiated by metallic elements."
2.	Papilloma (Papillomatosis) 09/13/1996 - "While 90% of the control animals were having papillomas on the 10th week of tumour initiation, only 10% of the curcumin III-treated animals, 20% of the curcumin II-treated animals, and 40% of the curcumin I-treated animals were having papillomas. "
3.	Ascites 07/20/1995 - "Curcumin III was found to be more active than the other two as a cytotoxic agent and in the inhibition of Ehrlich ascites tumour in mice (ILS 74.1%). "